The MLH1 c.1852_1853delinsGC (p.K618A) Variant in Colorectal Cancer: Genetic Association Study in 18,723 Individuals

Colorectal cancer is one of the most frequent neoplasms and an important cause of mortality in the developed world. Mendelian syndromes account for about 5% of the total burden of CRC, being Lynch syndrome and familial adenomatous polyposis the most common forms. Lynch syndrome tumors develop mainly as a consequence of defective DNA mismatch repair associated with germline mutations in MLH1, MSH2, MSH6 and PMS2. A significant proportion of variants identified by screening these genes correspond to missense or noncoding changes without a clear pathogenic consequence, and they are designated as “variants of uncertain significance”, being the c.1852_1853delinsGC (p.K618A) variant in the MLH1 gene a clear example. The implication of this variant as a low-penetrance risk variant for CRC was assessed in the present study by performing a case-control study within a large cohort from the COGENT consortium-COST Action BM1206 including 18,723 individuals (8,055 colorectal cancer cases and 10,668 controls) and a case-only genotype-phenotype correlation with several clinical and pathological characteristics restricted to the Epicolon cohort. Our results showed no involvement of this variant as a low-penetrance variant for colorectal cancer genetic susceptibility and no association with any clinical and pathological characteristics including family history for this neoplasm or Lynch syndrome.

[1]  Rodney J Scott,et al.  Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database , 2013, Nature Genetics.

[2]  J. Chang-Claude,et al.  Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility , 2013, PloS one.

[3]  Simon G. Coetzee,et al.  Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. , 2013, Gastroenterology.

[4]  J. Trojan,et al.  Expression Defect Size among Unclassified MLH1 Variants Determines Pathogenicity in Lynch Syndrome Diagnosis , 2013, Clinical Cancer Research.

[5]  V. Moreno,et al.  A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12 , 2013, BMC Genomics.

[6]  Ben Zhang,et al.  Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer , 2012, Nature Genetics.

[7]  Christopher D. Heinen,et al.  Pathological assessment of mismatch repair gene variants in Lynch syndrome: Past, present, and future , 2012, Human mutation.

[8]  L. Lipton,et al.  The TERT variant rs2736100 is associated with colorectal cancer risk , 2012, British Journal of Cancer.

[9]  Steven Gallinger,et al.  Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk , 2012, Nature Genetics.

[10]  F. Couch,et al.  The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumors. , 2012, Journal of Molecular Diagnostics.

[11]  R. Houlston.  COGENT (COlorectal cancer GENeTics) revisited. , 2012, Mutagenesis.

[12]  Steven Gallinger,et al.  Multiple Common Susceptibility Variants near BMP Pathway Loci GREM1, BMP4, and BMP2 Explain Part of the Missing Heritability of Colorectal Cancer , 2011, PLoS genetics.

[13]  Jeroen F. J. Laros,et al.  LOVD v.2.0: the next generation in gene variant databases , 2011, Human mutation.

[14]  A. Viel,et al.  Integrated analysis of unclassified variants in mismatch repair genes , 2011, Genetics in Medicine.

[15]  Á. Carracedo,et al.  Evidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome , 2011, BMC Medical Genetics.

[16]  E. Dermitzakis,et al.  Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33 , 2010, Nature Genetics.

[17]  T. Tuohy,et al.  Hereditary and familial colon cancer. , 2010, Gastroenterology.

[18]  C Schafmayer,et al.  COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer , 2009, British Journal of Cancer.

[19]  J. Houwing-Duistermaat,et al.  Enrichment of Low Penetrance Susceptibility Loci in a Dutch Familial Colorectal Cancer Cohort , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[20]  A. Tenesa,et al.  New insights into the aetiology of colorectal cancer from genome-wide association studies , 2009, Nature Reviews Genetics.

[21]  J. Tazi,et al.  A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects , 2008, Human mutation.

[22]  T. Ørntoft,et al.  The association between genetic variants in hMLH1 and hMSH2 and the development of sporadic colorectal cancer in the Danish population , 2008, BMC Medical Genetics.

[23]  Stephen B Gruber,et al.  Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms–mismatch repair (MAPP‐MMR) , 2008, Human mutation.

[24]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[25]  C. Ishioka,et al.  Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays. , 2007, Cancer research.

[26]  G. Abecasis,et al.  A note on exact tests of Hardy-Weinberg equilibrium. , 2005, American journal of human genetics.

[27]  M. Andreu,et al.  Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. , 2005, JAMA.

[28]  M. Benito,et al.  Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain , 2002, International journal of cancer.

[29]  A. Lindblom,et al.  Missense mutations in hMLH1 associated with colorectal cancer , 1999, Human Genetics.